Work

Novel ethical and policy issues in psychiatric uses of psychedelic substances

Year: 2022

Type: article

Abstract: Classic psychedelics and related substances have shown promising initial research results. However, they raise a number of relatively novel ethical and policy challenges in light of their psychoactive properties, their emergence from the unregulated "underground" settings in which they have been used, their rapid commercialization, and the means and speed with which they are moving from Schedule 1 status to legalized use. All of these issues are affected by the current limits to the evidence base on use of psychedelics. Here we survey these novel challenges, illustrating the issues raised regarding each, and offering suggestions for how to address them.

Source: Neuropharmacology

DOI: 10.1016/j.neuropharm.2022.109165

Authors: William R. Smith, Paul S. Appelbaum

Institutions: University of Pennsylvania, New York State Psychiatric Institute, Columbia University

Language: English

Topic: Psychedelics and Drug Studies

Subfield: Clinical Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,930